Insmed Incorporated
Insmed Incorporated（INSM）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · INSM · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
193
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Insmed Incorporated内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
INSM 季度内部人买卖趋势
INSM 内幕交易卖出 · INSM 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · INSM CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
INSM 高管卖出股份 · INSM 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 3, 2026 | Adsett Roger COO | Sale | 2,370 | $242K | Form 4 |
| Jun 3, 2026 | Bonstein Sara CFO | Sale | 2,404 | $246K | Form 4 |
| Jun 3, 2026 | Smith Michael Alexander Chief Legal Officer | Sale | 2,159 | $221K | Form 4 |
| Jun 3, 2026 | Lewis William Chair and CEO · Director | Sale | 7,605 | $778K | Form 4 |
| Jun 3, 2026 | Flammer Martina M.D. Chief Medical Officer | Sale | 2,566 | $262K | Form 4 |
| Jun 5, 2026 | Flammer Martina M.D. Chief Medical Officer | Sale | 1,858 | $193K | Form 4 |
| May 22, 2026 | Smith Michael Alexander Chief Legal Officer | Sale | 6,149 | $667K | Form 4 |
| May 18, 2026 | Lewis William Chair and CEO · Director | Option | 4,440 | $76K | Form 4 |
| May 18, 2026 | Lewis William Chair and CEO · Director | Option | 6,259 | $191K | Form 4 |
| May 18, 2026 | Lewis William Chair and CEO · Director | Sale | 5,753 | $606K | Form 4 |
| May 18, 2026 | Lewis William Chair and CEO · Director | Sale | 11,836 | $1.26M⚡ | Form 4 |
| May 18, 2026 | Lewis William Chair and CEO · Director | Sale | 7,975 | $853K | Form 4 |
| May 13, 2026 | Bonstein Sara CFO | Sale | 8,272 | $961K | Form 4 |
| May 13, 2026 | SCHAFER CAROL Director | Award | 3,305 | — | Form 4 |
| May 13, 2026 | Adsett Roger COO | Sale | 5,837 | $678K | Form 4 |
| May 13, 2026 | ANDERSON ELIZABETH M Director | Award | 3,305 | — | Form 4 |
| May 13, 2026 | Flammer Martina M.D. Chief Medical Officer | Sale | 4,470 | $504K | Form 4 |
| May 13, 2026 | Flammer Martina M.D. Chief Medical Officer | Sale | 3,384 | $393K | Form 4 |
| May 14, 2026 | Flammer Martina M.D. Chief Medical Officer | Sale | 10,479 | $1.23M⚡ | Form 4 |
| May 13, 2026 | Smith Michael Alexander Chief Legal Officer | Sale | 4,109 | $477K | Form 4 |
| May 13, 2026 | SHAROKY MELVIN MD Director | Award | 3,305 | — | Form 4 |
| May 13, 2026 | Brennan David R Director | Award | 3,305 | — | Form 4 |
| May 13, 2026 | Desjardins Clarissa Director | Award | 3,305 | — | Form 4 |
| May 13, 2026 | LEE LEO Director | Award | 3,305 | — | Form 4 |
| May 13, 2026 | Lewis William Chair and CEO · Director | Sale | 13,283 | $1.54M⚡ | Form 4 |
Smith Michael Alexander
Chief Legal Officer
日期
May 22
股数
6,149
均价
$108.47
总金额
$667K
Flammer Martina M.D.
Chief Medical Officer
日期
May 14
股数
10,479
均价
$117.54
总金额
$1.23M ⚡
Smith Michael Alexander
Chief Legal Officer
日期
May 13
股数
4,109
均价
$116.18
总金额
$477K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 INSM 内幕交易
INSM 内幕交易
Insmed Incorporated（INSM）内幕交易数据来源于公司内部人（包括Lewis William (Chair and CEO · Director), Smith Michael Alexander (Chief Legal Officer), Flammer Martina M.D. (Chief Medical Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。INSM内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Insmed Incorporated机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
INSM 内幕交易 · 5个问题Insmed Incorporated（INSM）的内部人包括高管和董事，如Lewis William (Chair and CEO · Director), Smith Michael Alexander (Chief Legal Officer), Flammer Martina M.D. (Chief Medical Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026